Ernexa Therapeutics (ERNAW) Cash from Discontinued Operations (2010 - 2011)
Ernexa Therapeutics (ERNAW) reported Cash from Discontinued Operations of 26000.0 for Q3 2011, up 124.3% on a YoY basis from 11591.67 in Q3 2010, and up 124.3% quarter-over-quarter from 107000.0 in Q3 2010.
Ernexa Therapeutics (ERNAW) Cash from Discontinued Operations (2010 - 2011) Analysis & Trends
Ernexa Therapeutics has reported Cash from Discontinued Operations for 2 years, with the latest figure at 26000.0 in Q3 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -59.14 Mn |
| 10 | Ernexa Therapeutics | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2011 | 26,000.00 |
| Sep 30, 2011 | 26,000.00 |
| Sep 30, 2010 | -107,000.00 |
| Sep 30, 2010 | -107,000.00 |